×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: Britain | Earns | AstraZeneca

AstraZeneca Says 4th-Q Earns Triple on Cancer Drugs Sales

AstraZeneca Says 4th-Q Earns Triple on Cancer Drugs Sales

Thursday, 11 February 2021 03:00 AM

LONDON (AP) — AstraZeneca, co-developer of one of the first COVID-19 vaccines to be authorized for widespread use, says fourth-quarter earnings more than tripled amid strong sales of its cancer drugs.

The Anglo-Swedish company said Thursday that net income rose to $1.01 billion from $313 million in the same quarter a year earlier.

Drug sales increased 11% to $7.41 billion, driven by a 24% increase in cancer treatments.

The company posted $2 million of revenue from its COVID-19 vaccine, which it has pledged to supply on a non-profit basis during the pandemic, and said it would begin reporting sales of the vaccine separately beginning in the next quarter.

© Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


GlobalTalk
AstraZeneca, co-developer of one of the first COVID-19 vaccines to be authorized for widespread use, says fourth-quarter earnings more than tripled amid strong sales of its cancer drugs.The Anglo-Swedish company said Thursday that net income rose to $1.01 billion from $313...
Britain,Earns,AstraZeneca
107
2021-00-11
Thursday, 11 February 2021 03:00 AM
Newsmax Media, Inc.
More Articles
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved